Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| MODERNA | 14 | 16 | -0,10 % | ||
| REGENERON PHARMACEUTICALS | 10 | 22 | -2,11 % | ||
| BIONTECH | 5 | 13 | -0,54 % | ||
| TEVOGEN BIO | 4 | 7 | -2,55 % | ||
| ALLOGENE THERAPEUTICS | 4 | 6 | -11,79 % | ||
| ALNYLAM PHARMACEUTICALS | 3 | 9 | -0,72 % | ||
| ILLUMINA | 3 | - | +0,01 % | ||
| BIOMARIN PHARMACEUTICAL | 2 | 12 | -0,28 % | ||
| LENZ THERAPEUTICS | 2 | 5 | +0,40 % | ||
| SYNDAX PHARMACEUTICALS | 2 | 1 | -4,62 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12:54 | Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion | 19 | Benzinga.com | ||
| 07:10 | Regulatory tracker: AstraZeneca's Imfinzi stomach cancer expansion bid snags FDA priority review | 4 | FiercePharma | ||
| 06:37 | How Will VRTX Stock React To Its Upcoming Earnings? | 8 | Forbes | ||
| 01:15 | Gold Fields, Kiniksa Join Best Stock Lists As They Defy Slump And Shares Pop: See New Names On IBD 50, IPO Leaders And More | 4 | Investor's Business Daily | ||
| 00:06 | Assessing 4D Molecular Therapeutics: Insights From 5 Financial Analysts | 14 | Benzinga.com | ||
| Fr | Syndax Pharmaceuticals Q2 2025 Earnings Preview | 2 | Seeking Alpha | ||
| Fr | ILLUMINA, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| Fr | What to Expect from Praxis Precision Medicine's Earnings | 2 | Benzinga.com | ||
| Fr | Taysha Gene Therapies, Inc.: Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 22 | GlobeNewswire (Europe) | DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based... ► Artikel lesen | |
| Fr | A Glimpse of Prothena Corp's Earnings Potential | 1 | Benzinga.com | ||
| Fr | Syndax Pharmaceuticals' Earnings: A Preview | 1 | Benzinga.com | ||
| Fr | Xenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 23 | GlobeNewswire (Europe) | VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing... ► Artikel lesen | |
| Fr | ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 21 | GlobeNewswire (Europe) | SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address... ► Artikel lesen | |
| Fr | BIOMARIN PHARMACEUTICAL INC - 8-K, Current Report | 4 | SEC Filings | ||
| Fr | Amneal Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | What to Expect from Ardelyx's Earnings | 2 | Benzinga.com | ||
| Fr | Prime Medicine, Inc.: Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares | 1 | GlobeNewswire (USA) | ||
| Fr | Moderna, Inc. - 10-Q, Quarterly Report | 15 | SEC Filings | ||
| Fr | Tevogen Bio Inc: Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders | 57 | GlobeNewswire (Europe) | WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen... ► Artikel lesen | |
| Fr | Fördermittel für KI-Plattform: Aktie von Tevogen Bio legt zu | - | Investing.com Deutsch |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .